Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Standard BioTools Inc. - Common Stock
(NQ:
LAB
)
1.980
-0.150 (-7.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Standard BioTools Inc. - Common Stock
< Previous
1
2
Next >
Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying
August 27, 2024
Via
Benzinga
Around $2M Bet On This Health Care Stock? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
August 19, 2024
Via
Benzinga
$1.7M Bet On Standard BioTools? Check Out These 3 Stocks Under $5 Insiders Are Aggressively Buying
August 12, 2024
Via
Benzinga
MercadoLibre Posts Upbeat Results, Joins Integral Ad Science, Willdan Group, Fresh Del Monte Produce And Other Big Stocks Moving Higher On Friday
August 02, 2024
Via
Benzinga
Why Carvana Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
August 01, 2024
Via
Benzinga
LAB Stock Earnings: Standard BioTools Reported Results for Q2 2024
July 31, 2024
Standard BioTools just reported results for the second quarter of 2024.
Via
InvestorPlace
LAB Stock Earnings: Standard BioTools Reported Results for Q1 2024
May 08, 2024
Standard BioTools just reported results for the first quarter of 2024.
Via
InvestorPlace
Western Digital, Udemy, Teladoc Health And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
August 01, 2024
Via
Benzinga
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
May 23, 2024
Via
Benzinga
$3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
May 20, 2024
Via
Benzinga
Quantum-Si And 2 Other Penny Stocks Insiders Are Buying
March 07, 2024
The Dow Jones index closed higher by around 75 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
December 21, 2023
From
SomaLogic
Via
GlobeNewswire
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools
December 20, 2023
From
Skye Fund III, LLC
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
December 17, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
December 11, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Proposed Merger Between Standard BioTools Inc. (NASDAQ: LAB) and SomaLogic, Inc. (NASDAQ: SLGC)
December 06, 2023
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
STANDARD BIOTOOLS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Standard BioTools Inc. - LAB
December 05, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
STANDARD BIOTOOLS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Standard BioTools Inc. - LAB
October 06, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: LiveVox Holdings, Inc. (Nasdaq - LVOX), Standard BioTools Inc. (Nasdaq - LAB), PFSweb, Inc. (Nasdaq – PFSW), Hostess Brands, Inc. (Nasdaq – TWNK)
October 04, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 04, 2023
Via
Benzinga
LAB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Standard BioTools Inc. Is Fair to Shareholders
October 04, 2023
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 04, 2023
Via
Benzinga
Standard BioTools Get a Buy Rating, Analyst Cites Unique Technology, Management and Board
July 12, 2023
KeyBanc Capital Markets initiated coverage on Standard BioTools Inc (NASDAQ: LAB) with an Overweight rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2023
July 12, 2023
Via
Benzinga
Earnings Scheduled For February 14, 2023
February 14, 2023
Companies Reporting Before The Bell • WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
Via
Benzinga
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
November 28, 2022
Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo.
Via
Benzinga
$1.4 Million Bet On Planet Green Holdings? Check Out These 5 Penny Stocks Insiders Are Buying
August 08, 2022
U.S. stock futures traded slightly higher this morning on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday
November 14, 2022
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday.
Via
Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
August 10, 2022
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.
Via
Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
August 09, 2022
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.